| Announce Date | 10/24/2025 |
| EPS Normalized Actual | $3.88 (Beat by $0.18) |
| EPS GAAP Actual | $3.88 (Beat by $0.18) |
| Revenue Actual | $12.907B |
| Revenue Surprise | Beat by $12907M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 21.24 | 16.16 | 20.92322 | 21.7617 | 4 |
| Dec 2028 | 20.945 | 16.39 | 20.67994 | 21.26404 | 6 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.94 | 3.94 | 12.907B | 100% | 12907M |
| FQ2 2025 (Jun 2025) | 3.78 | 3.78 | 13.041B | 8.17% | 13041M |
| FQ1 2025 (Mar 2025) | 3.69 | 3.69 | 12.223B | 100% | 12223M |
| FQ4 2024 (Dec 2024) | 4.2 | 4.2 | 13.338B | 20.75% | 13338M |
| FQ3 2024 (Sep 2024) | 3.39 | 3.39 | 0B | -INF% | 0M |
| FQ2 2024 (Jun 2024) | 3.3 | 3.3 | 11.976B | 17.49% | 11976M |
| FQ1 2024 (Mar 2024) | 2.92 | 2.92 | 0B | NAN% | 0M |
| FQ4 2023 (Oct 2023) | 3.07 | 3.07 | 10.571B | 100% | 10571M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 5.23163 | -- | 5.04935 | 5.35868 | 2 |
| FQ3 2027 (Sep 2027) | 4.59999 | -- | 4.43972 | 4.7117 | 2 |
| FQ2 2027 (Jun 2027) | 4.36209 | -- | 4.21011 | 4.46802 | 2 |
| FQ1 2027 (Mar 2027) | 3.97339 | -- | 3.83495 | 4.06988 | 2 |
| FQ4 2026 (Oct 2026) | 4.41105 | -- | 4.08766 | 4.59504 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 15.06B | -- | 14.65B | 15.34B | 3 |
| FQ3 2027 (Sep 2027) | 14B | -- | 13.63B | 14.26B | 3 |
| FQ2 2027 (Jun 2027) | 13.66B | -- | 13.29B | 13.91B | 3 |
| FQ1 2027 (Mar 2027) | 12.76B | -- | 12.41B | 12.99B | 3 |
| FQ4 2026 (Oct 2026) | 12.67B | -- | 11.95B | 13.07B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
0
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.94 | 3.94 | 100% | |
| FQ2 2025 (Jun 2025) | 3.78 | 3.78 | 100% | |
| FQ1 2025 (Mar 2025) | 3.69 | 3.69 | 100% | |
| FQ4 2024 (Dec 2024) | 4.2 | 4.2 | 100% | |
| FQ3 2024 (Sep 2024) | 3.39 | 3.39 | 100% | |
| FQ2 2024 (Jun 2024) | 3.3 | 3.3 | 100% | |
| FQ1 2024 (Mar 2024) | 2.92 | 2.92 | 100% | |
| FQ4 2023 (Oct 2023) | 3.07 | 3.07 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $12.91B | $12907M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $13.04B | $13041M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $12.22B | $12223M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $13.34B | $13338M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $11.98B | $11976M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2023 (Oct 2023) | $0B | $10.57B | $10571M | 100% |